Novatim

Novatim focuses on the research and development and clinical application of innovative drugs for tumor immunotherapy in the biopharmaceutical field. Based on clinical needs and its corporate positioning in tumor immunotherapy, Novatim has established R&D platforms for bifunctional antibodies, ADCs, CAR-T for solid tumors, and CAR-T for hematologic tumors, developing nearly 8 FIC/BIC products.